Chinese Journal of Dermatology ›› 2026, Vol. 59 ›› Issue (9): 915-918.doi: 10.35541/cjd.20220878
• Reviews • Previous Articles
Ma Jing, Luan Chao, Chen Kun
Received:2022-12-07
Revised:2024-02-26
Online:2026-09-15
Published:2026-09-03
Contact:
Chen Kun
E-mail:kunchen181@aliyun.com
Ma Jing, Luan Chao, Chen Kun. Lipid metabolism-related proteins in psoriasis[J]. Chinese Journal of Dermatology, 2026, 59(9): 915-918.doi:10.35541/cjd.20220878
| [1] | Parisi R, Symmons DP, Griffiths CE, et al. Global epidemiology of psoriasis: a systematic review of incidence and prevalence[J]. J Invest Dermatol, 2013,133(2):377⁃385. doi: 10.1038/jid. 2012.339. |
| [2] | Gui XY, Yu XL, Jin HZ, et al. Prevalence of metabolic syndrome in Chinese psoriasis patients: a hospital⁃based cross⁃sectional study[J]. J Diabetes Investig, 2018,9(1):39⁃43. doi: 10.1111/jdi.12663. |
| [3] | Hsu S, Green LJ, Lebwohl MG, et al. Comparable efficacy and safety of brodalumab in obese and nonobese patients with psoriasis: analysis of two randomized controlled trials[J]. Br J Dermatol, 2020,182(4):880⁃888. doi: 10.1111/bjd.18327. |
| [4] | Owczarczyk⁃Saczonek A, Purzycka⁃Bohdan D, Nedoszytko B, et al. Pathogenesis of psoriasis in the "omic" era. Part Ⅲ. Metabolic disorders, metabolomics, nutrigenomics in psoriasis[J]. Postepy Dermatol Alergol, 2020,37(4):452⁃467. doi: 10.5114/ada.2020.98284. |
| [5] | Teklu M, Parel PM, Mehta NN. Psoriasis and cardiometabolic diseases: the impact of inflammation on vascular health[J]. Psoriasis (Auckl), 2021,11:99⁃108. doi: 10.2147/PTT.S320016. |
| [6] | Peralta C, Hamid P, Batool H, et al. Psoriasis and metabolic syndrome: comorbidities and environmental and therapeutic implications[J]. Cureus, 2019,11(12):e6369. doi: 10.7759/cureus.6369. |
| [7] | Kovács D, Fazekas F, Oláh A, et al. Adipokines in the skin and in dermatological diseases[J]. Int J Mol Sci, 2020,21(23):9048. doi: 10.3390/ijms21239048. |
| [8] | Hu D, Yang Y, Peng DQ. Increased sortilin and its independent effect on circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) in statin⁃naive patients with coronary artery disease[J]. Int J Cardiol, 2017,227:61⁃65. doi: 10.1016/j.ijcard. 2016.11.064. |
| [9] | Luan C, Chen X, Zhu Y, et al. Potentiation of psoriasis⁃like inflammation by PCSK9[J]. J Invest Dermatol, 2019,139(4):859⁃867. doi: 10.1016/j.jid.2018.07.046. |
| [10] | Zhang R, Wang YH, Shi X, et al. Sortilin regulates keratinocyte proliferation and apoptosis through the PI3K⁃AKT signaling pathway[J]. Life Sci, 2021,278:119630. doi: 10.1016/j.lfs.2021. 119630. |
| [11] | Garshick MS, Baumer Y, Dey AK, et al. Characterization of PCSK9 in the blood and skin of psoriasis[J]. J Invest Dermatol, 2021,141(2):308⁃315. doi: 10.1016/j.jid.2020.05.115. |
| [12] | Gao Y, Lu J, Bao X, et al. Inhibition of phospholipases suppresses progression of psoriasis through modulation of inflammation[J]. Exp Biol Med (Maywood), 2021,246(11):1253⁃1262. doi: 10.1177/1535370221993424. |
| [13] | Shao S, Chen J, Swindell WR, et al. Phospholipase A2 enzymes represent a shared pathogenic pathway in psoriasis and pityriasis rubra pilaris[J]. JCI Insight, 2021,6(20):e151911 [pii]. doi: 10.1172/jci.insight.151911. |
| [14] | Singh R, Chen YL, Ng SW, et al. Phospholipase activity of acyloxyacyl hydrolase induces IL⁃22⁃producing CD1a⁃autoreactive T cells in individuals with psoriasis[J]. Eur J Immunol, 2022,52(3):511⁃524. doi: 10.1002/eji.202149485. |
| [15] | Sparks CE, Sparks RP, Sparks JD. The enigmatic role of sortilin in lipoprotein metabolism[J]. Curr Opin Lipidol, 2015,26(6):598⁃600. doi: 10.1097/MOL.0000000000000244. |
| [16] | Nowowiejska J, Baran A, Krahel JA, et al. Serum cholesteryl ester transfer protein (CETP) and sortilin (SORT) in patients with psoriasis with relation to systemic treatment[J]. Metabolites, 2022,12(4):340. doi: 10.3390/metabo12040340. |
| [17] | Duvetorp A, Olsen RS, Nyström H, et al. Expression of low⁃density lipoprotein⁃related receptors 5 and 6 (LRP5/6) in psoriasis skin[J]. Exp Dermatol, 2017,26(11):1033⁃1038. doi: 10.1111/exd.13362. |
| [18] | Pasmatzi E, Papadionysiou C, Monastirli A, et al. Galectin 1 in dermatology: current knowledge and perspectives[J]. Acta Dermatovenerol Alp Pannonica Adriat, 2019,28(1):27⁃31. |
| [19] | Pasmatzi E, Papadionysiou C, Monastirli A, et al. Galectin 3: an extraordinary multifunctional protein in dermatology. Current knowledge and perspectives[J]. An Bras Dermatol, 2019,94(3):348⁃354. doi: 10.1590/abd1806⁃4841.20198426. |
| [20] | Corrêa MP, Correia⁃Silva RD, Sasso G, et al. Expression pattern and immunoregulatory roles of galectin⁃1 and galectin⁃3 in atopic dermatitis and psoriasis[J]. Inflammation, 2022,45(3):1133⁃1145. doi: 10.1007/s10753⁃021⁃01608⁃7. |
| [21] | Shih CM, Huang CY, Wang KH, et al. Oxidized low⁃density lipoprotein⁃deteriorated psoriasis is associated with the upregulation of lox⁃1 receptor and IL⁃23 expression in vivo and in vitro[J]. Int J Mol Sci, 2018,19(9):2610. doi: 10.3390/ijms19092610. |
| [22] | Wang H, Yang G, Zhang Q, et al. Apremilast ameliorates ox⁃LDL⁃induced endothelial dysfunction mediated by KLF6[J]. Aging (Albany NY), 2020,12(19):19012⁃19021. doi: 10.18632/aging. 103665. |
| [23] | Gupta M, Mahajan VK, Mehta KS, et al. Peroxisome proliferator⁃activated receptors (PPARs) and PPAR agonists: the 'future' in dermatology therapeutics?[J]. Arch Dermatol Res, 2015,307(9):767⁃780. doi: 10.1007/s00403⁃015⁃1571⁃1. |
| [24] | Sobolev V, Nesterova A, Soboleva A, et al. Analysis of PPARγ signaling activity in psoriasis[J]. Int J Mol Sci, 2021,22(16):8603. doi: 10.3390/ijms22168603. |
| [25] | Blunder S, Pavel P, Minzaghi D, et al. PPARdelta in affected atopic dermatitis and psoriasis: a possible role in metabolic reprograming[J]. Int J Mol Sci, 2021,22(14):7354. doi: 10. 3390/ijms22147354. |
| [26] | Hao Y, Zhu YJ, Zou S, et al. Metabolic syndrome and psoriasis: mechanisms and future directions[J]. Front Immunol, 2021,12:711060. doi: 10.3389/fimmu.2021.711060. |
| [27] | Oh YJ, Lim HK, Choi JH, et al. Serum leptin and adiponectin levels in Korean patients with psoriasis[J]. J Korean Med Sci, 2014,29(5):729⁃734. doi: 10.3346/jkms.2014.29.5.729. |
| [28] | Wang Y, Huo J, Zhang D, et al. Chemerin/ChemR23 axis triggers an inflammatory response in keratinocytes through ROS⁃sirt1⁃NF⁃κB signaling[J]. J Cell Biochem, 2019,120(4):6459⁃6470. doi: 10.1002/jcb.27936. |
| [29] | Zou Q, Si J, Guo Y, et al. Association between serum visfatin levels and psoriasis and their correlation with disease severity: a meta⁃analysis[J]. J Int Med Res, 2021,49(3):300060521100 2381. doi: 10.1177/03000605211002381. |
| [30] | Wang HM, Wu C, Jiang YY, et al. Retinol and vitamin A metabolites accumulate through RBP4 and STRA6 changes in a psoriasis murine model[J]. Nutr Metab (Lond), 2020, 17:5. doi: 10.1186/s12986⁃019⁃0423⁃y. |
| [31] | Shehata WA, Basha MA, Gayed IM, et al. Relationship between disease severity and fetuin⁃A levels in patients with psoriasis[J]. Indian J Dermatol Venereol Leprol, 2020,86(5):586⁃588. doi: 10.4103/ijdvl.IJDVL_355_19. |
| [32] | Aizawa N, Ishiuji Y, Tominaga M, et al. Relationship between the degrees of itch and serum lipocalin⁃2 levels in patients with psoriasis[J]. J Immunol Res, 2019,2019:8171373. doi: 10.1155/2019/8171373. |
| [33] | Chekol Abebe E, Tilahun Muche Z, Behaile T/Mariam A, et al. Role of fetuin⁃A in the pathogenesis of psoriasis and its potential clinical applications[J]. Clin Cosmet Investig Dermatol, 2022,15:595⁃607. doi: 10.2147/CCID.S356801. |
| [34] | 胡煜, 栾超, 练霓, 等. 银屑病患者血浆中前蛋白转化酶枯草溶菌素9的表达及对外周血CD4+ T细胞活化的影响[J]. 中华皮肤科杂志, 2019,52(2):90⁃93. doi: 10.3760/cma.j.issn.0412⁃4030.2019.02.004. |
| [1] | China Dermatologist Association, Chinese Society of Dermatology, Dermatology Branch of China International Exchange and Promotive Association for Medical and Health Care, Dermatology Branch of China Alliance for Rare Diseases. Expert consensus on the long-term management of plaque psoriasis with biologic agents (2026 edition) [J]. Chinese Journal of Dermatology, 2026, 59(9): 827-843. |
| [2] | Chen Xingyu, Yao Xu. Role of neutrophils in inflammatory dermatoses [J]. Chinese Journal of Dermatology, 2026, 59(9): 905-910. |
| [3] | Shi Rongcan¹, ², Yu Zengyang², ³, Luo Qingqiong², Ma Rui¹, ², Jiang Xingyu¹, ², Wang Yuanyuan¹, ², Cai Jiangluyi¹, ², Shi Yuling¹, ². Palmitoyl-proteomic profiles of psoriatic lesions and their role in inflammatory responses: a preliminary study [J]. Chinese Journal of Dermatology, 2026, 59(8): 738-749. |
| [4] | Writing Committee Expert Group on “Diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement ( edition)”. Diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement (2026 edition) [J]. Chinese Journal of Dermatology, 2026, 59(8): 717-727. |
| [5] | Wei Jin¹, Yan Huiwen¹, Zhang Jianzhong², Lun Wenhui¹. Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis complicated by HIV infection: a clinical observation of 10 cases [J]. Chinese Journal of Dermatology, 2026, 59(7): 671-674. |
| [6] | Yuwen Tianyi¹, Zhou Zizhen¹, Tian Jingyu¹, Chen Sihan², Li Min², Zhang Fengyuan¹, Gu Heng, ², Chen Xu, ². Expression of the glutaminase 1/ammonia metabolism axis in keratinocytes in ultraviolet B-induced acute skin injury and psoriatic skin inflammation [J]. Chinese Journal of Dermatology, 2026, 59(7): 654-661. |
| [7] | Zhang Xiaoxu, Luo Suju. Efficacy and safety of upadacitinib in the treatment of six cases of palmoplantar pustulosis [J]. Chinese Journal of Dermatology, 2026, 59(5): 459-463. |
| [8] | Chinese Association of Rehabilitation Dermatology, Combination of Traditional and Western Medicine Dermatology. Expert consensus on the diagnosis, treatment and rehabilitation of psoriasis in the elderly (2026 edition) [J]. Chinese Journal of Dermatology, 2026, 59(5): 407-418. |
| [9] | Chinese Society of Dermatology, China Dermatologist Association, Dermatology Branch of China International Exchange and Promotive Association for Medical and Health Care, Dermatology Branch of China Alliance for Rare Diseases. Expert consensus on fecal microbiota transplantation in the treatment of psoriasis (2026 edition) [J]. Chinese Journal of Dermatology, 2026, 59(5): 427-435. |
| [10] | Chen Tingnan, Liang Jingyao, Deng Shilin, Shu Zhirong, Zhang Xibao. Immunophenotypic switching between psoriasis and atopic dermatitis after biologic therapy: a systematic review of clinical features, mechanisms and management strategies [J]. Chinese Journal of Dermatology, 2026, 59(5): 474-481. |
| [11] | Wang Yongxing, Ding Yuan. Induced psoriasis-like animal models [J]. Chinese Journal of Dermatology, 2026, 0(3): 20250129-e20250129. |
| [12] | Chen Ruolin, Cao Yan. Hypoxia-inducible factor-1α in autoimmune skin diseases [J]. Chinese Journal of Dermatology, 2026, 0(3): 20250202-e20250202. |
| [13] | Zhu Jiayue, Feng Hao, Jin Hongzhong. Artificial intelligence-assisted diagnosis and treatment of psoriasis and its telemedicine applications [J]. Chinese Journal of Dermatology, 2026, 0(3): 20230051-e20230051. |
| [14] | Zhou Yuting, Song Qinghua, Wang Wenhui. Susceptibility genes of generalized pustular psoriasis [J]. Chinese Journal of Dermatology, 2026, 0(3): 20240211-e20240211. |
| [15] | Guo Lan, Jin Hongzhong. Tryptophan and arginine metabolism in immune regulation and their role in the pathogenesis of psoriasis [J]. Chinese Journal of Dermatology, 2026, 0(3): 20240377-e20240377. |
|